FDA recall record

Anatox 1 recall — FDA F-1005-2023

Elevated lead levels

Class IIIclassification
F-1005-2023official record ID
Jul 5, 2023report date

Recall record at a glance

Official recordF-1005-2023
CategoryFood Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmAnatox Inc.
Report dateJul 5, 2023
Recall initiation dateMay 26, 2023
Quantity6,777 bottles
LocationRichland, MO, United States

Official product description

1. VIT-RA-TOX Calphonite #38, 15 Fl. oz. (444 ml) in an amber glass bottle; 2. Sonne's Calphonite #2, 15 Fl. oz. (444 ml) in an amber glass bottle

Why the product was recalled

Elevated lead levels

Distribution information

Distributors, retailers, and consumers in AL, AZ, CA, CT, CO, FL, GA, IL, IN, KS, KY, MA, MD, MN, MO, NC, NM, NY, OH, OR, PA, TN, TX, UT, VA, VT, WI

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.